4-phenylbutyric acid has been researched along with Kawasaki Disease in 1 studies
4-phenylbutyric acid: RN refers to the parent cpd
4-phenylbutyric acid : A monocarboxylic acid the structure of which is that of butyric acid substituted with a phenyl group at C-4. It is a histone deacetylase inhibitor that displays anticancer activity. It inhibits cell proliferation, invasion and migration and induces apoptosis in glioma cells. It also inhibits protein isoprenylation, depletes plasma glutamine, increases production of foetal haemoglobin through transcriptional activation of the gamma-globin gene and affects hPPARgamma activation.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Shi, Z | 1 |
| Yin, Y | 1 |
| Li, C | 1 |
| Ding, H | 1 |
| Mu, N | 1 |
| Wang, Y | 1 |
| Jin, S | 1 |
| Ma, H | 1 |
| Liu, M | 1 |
| Zhou, J | 1 |
1 other study available for 4-phenylbutyric acid and Kawasaki Disease
| Article | Year |
|---|---|
Lipocalin-2-induced proliferative endoplasmic reticulum stress participates in Kawasaki disease-related pulmonary arterial abnormalities.
Topics: Animals; Antineoplastic Agents; Disease Models, Animal; Endoplasmic Reticulum Stress; Lipocalin-2; M | 2021 |